U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C2H3NO3
Molecular Weight 89.0501
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OXAMIC ACID

SMILES

NC(=O)C(O)=O

InChI

InChIKey=SOWBFZRMHSNYGE-UHFFFAOYSA-N
InChI=1S/C2H3NO3/c3-1(4)2(5)6/h(H2,3,4)(H,5,6)

HIDE SMILES / InChI

Molecular Formula C2H3NO3
Molecular Weight 89.0501
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Synthesis of new oxamide-based ligand and its coordination behavior towards copper(II) ion: spectral and electrochemical studies.
2008-04
In vitro PAI-1 inhibitory activity of oxalamide derivatives.
2008-04
Cyclic stretch of human lung cells induces an acidification and promotes bacterial growth.
2008-03
Structure and mechanism of HpcH: a metal ion dependent class II aldolase from the homoprotocatechuate degradation pathway of Escherichia coli.
2007-11-02
Modulating Electronic Coupling Using O- and S-donor Linkers.
2007-09-17
Lactate dehydrogenase undergoes a substantial structural change to bind its substrate.
2007-09-01
Design, synthesis, and biological evaluation of Plasmodium falciparum lactate dehydrogenase inhibitors.
2007-08-09
Negligible direct lactate oxidation in subsarcolemmal and intermyofibrillar mitochondria obtained from red and white rat skeletal muscle.
2007-08-01
Aerobically derived lactate stimulates revascularization and tissue repair via redox mechanisms.
2007-08
Lactate, not pyruvate, is neuronal aerobic glycolysis end product: an in vitro electrophysiological study.
2007-07-13
Solid-phase synthesis of carboxylic and oxamic acids via OsO4/NaIO4/HMTA-mediated oxidative cleavage of acetylenic peptides.
2007-06-21
Molecular-programmed self-assembly of homo- and heterometallic penta- and hexanuclear coordination compounds: synthesis, crystal structures, and magnetic properties of ladder-type CuII2MIIx (M=Cu, Ni; x=3, 4) oxamato complexes with CuII2 metallacyclophane cores.
2007-05-28
In vitro and in vivo trypanocidal activity of the ethyl esters of N-allyl and N-propyl oxamates using different Trypanosoma cruzi strains.
2007-04
Mechanisms of copper ion mediated Huntington's disease progression.
2007-03-28
L-lactate metabolism in potato tuber mitochondria.
2007-03
Generation of oxamic acid libraries: antimalarials and inhibitors of Plasmodium falciparum lactate dehydrogenase.
2007-02-24
Heteronuclear complexes of macrocyclic oxamide with co-ligands: syntheses, crystal structures, and magnetic properties.
2007-02-19
Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins.
2007-02
One-pot solid-phase glycoblotting and probing by transoximization for high-throughput glycomics and glycoproteomics.
2007
Ligand design for heterobimetallic single-chain magnets: synthesis, crystal structures, and magnetic properties of MIICuII (M=Mn, Co) chains with sterically hindered methyl-substituted phenyloxamate bridging ligands.
2007
Design of new heteroscorpionate ligands and their coordinative ability toward Group 4 transition metals; an efficient synthetic route to obtain enantiopure ligands.
2006-09-28
Secondary bacterial keratitis associated with shield ulcer caused by vernal conjunctivitis.
2006-09
Cisplatin-induced toxicity is associated with platinum deposition in mouse kidney mitochondria in vivo and with selective inactivation of the alpha-ketoglutarate dehydrogenase complex in LLC-PK1 cells.
2006-07-25
Organometallic chemistry of amidate complexes. accelerating effect of bidentate ligands on the reductive elimination of N-aryl amidates from palladium(II).
2006-07-19
Chemical hybridizing agents for chickpea (Cicer arietinum L.): leads from QSAR analysis of ethyl oxanilates and pyridones.
2006-03-08
Development of EPA method 535 for the determination of chloroacetanilide and other acetamide herbicide degradates in drinking water by solid-phase extraction and liquid chromatography/tandem mass spectrometry.
2006-03-04
A clinicopathological analysis of the efficacy of lodoxamide 0.1% eye drops on the conjunctiva of patients with vernal keratoconjunctivitis seen at Guinness Eye Centre, Lagos University Teaching Hospital.
2006-03
Enantiomeric separation of metolachlor and its metabolites using LC-MS and CZE.
2006-03
Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted.
2006-02-27
Chloroacetaldehyde: mode of antitumor action of the ifosfamide metabolite.
2006-02
The development of cement and concrete additive: based on xylonic acid derived via bioconversion of xylose.
2006
3-(5-Chloro-2,4-dihydroxyphenyl)-pyrazole-4-carboxamides as inhibitors of the Hsp90 molecular chaperone.
2005-12-01
Synthesis and evaluation of thiazole carboxamides as vanilloid receptor 1 (TRPV1) antagonists.
2005-12-01
Massive insulin secretion in response to anaerobic exercise in exercise-induced hyperinsulinism.
2005-11
Acrosome reaction in bovine spermatozoa: role of reactive oxygen species and lactate dehydrogenase C4.
2005-10-30
Are neutral chloroacetamide herbicide degradates of potential environmental concern? Analysis and occurrence in the upper Chesapeake Bay.
2005-09-01
Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
2005-09-01
The approach to the Michaelis complex in lactate dehydrogenase: the substrate binding pathway.
2005-09
Synthesis of bis-(methyl 3,4,6-tri-O-acetyl-D-glucopyranosid-2-yl)-oxamides.
2005-07-04
Determination of lactate dehydrogenase (LDH) activity in milk by a fluorometric assay.
2005-05
Trypanocidal activity of N-isopropyl oxamate on cultured epimastigotes and murine trypanosomiasis using different Trypanosoma cruzi strains.
2005-04
Stereoselective allyl amine synthesis through enantioselective addition of diethylzinc and [1,3]-chirality transfer: synthesis of lentiginosine and polyoxamic acid derivative.
2005-03-04
Differential sensitivity to 2-deoxy-D-glucose between two pancreatic cell lines correlates with GLUT-1 expression.
2005-03
NAD(H) enhances the Cu(II)-mediated inactivation of lactate dehydrogenase by increasing the accessibility of sulfhydryl groups.
2005-01
Urea lesion formation in DNA as a consequence of 7,8-dihydro-8-oxoguanine oxidation and hydrolysis provides a potent source of point mutations.
2005-01
Trypanosoma cruzi: inhibition of alpha-hydroxyacid dehydrogenase isozyme II by N-allyl and N-propyl oxamates and their effects on intact epimastigotes.
2004-12
Degradation of metolachlor in bare and vegetated soils and in simulated water-sediment systems.
2004-11
[Monomers for oligonucleotide synthesis with linkers carrying reactive residues: II. Synthesis of phosphoamidites based of uridine and cytosine and containing a linker with methoxyoxalamide groups in position 2'].
2004-09-04
[Monomers for oligonucleotide synthesis with linkers carrying reactive residues: I. Synthesis of deoxynucleoside derivatives with methoxyoxalamide groups in heterocyclic bases].
2004-09-04
96-well plate assay for sublethal metabolic activity.
2004-08
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 21:21:52 GMT 2025
Edited
by admin
on Mon Mar 31 21:21:52 GMT 2025
Record UNII
QU60N5OPLG
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-47001
Preferred Name English
OXAMIC ACID
MI  
Systematic Name English
FORMIC ACID, (AMINOCARBONYL)-
Common Name English
OXAMIC ACID [MI]
Common Name English
NSC-53102
Code English
OXALIC ACID MONOAMIDE
Systematic Name English
NSC-49416
Code English
GLYCINE, 2-OXO-
Systematic Name English
ACETIC ACID, AMINOOXO-
Common Name English
AMINOOXOACETIC ACID
Systematic Name English
OXALAMIC ACID
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID6060052
Created by admin on Mon Mar 31 21:21:52 GMT 2025 , Edited by admin on Mon Mar 31 21:21:52 GMT 2025
PRIMARY
CAS
471-47-6
Created by admin on Mon Mar 31 21:21:52 GMT 2025 , Edited by admin on Mon Mar 31 21:21:52 GMT 2025
PRIMARY
PUBCHEM
974
Created by admin on Mon Mar 31 21:21:52 GMT 2025 , Edited by admin on Mon Mar 31 21:21:52 GMT 2025
PRIMARY
FDA UNII
QU60N5OPLG
Created by admin on Mon Mar 31 21:21:52 GMT 2025 , Edited by admin on Mon Mar 31 21:21:52 GMT 2025
PRIMARY
NSC
47001
Created by admin on Mon Mar 31 21:21:52 GMT 2025 , Edited by admin on Mon Mar 31 21:21:52 GMT 2025
PRIMARY
DRUG BANK
DB03940
Created by admin on Mon Mar 31 21:21:52 GMT 2025 , Edited by admin on Mon Mar 31 21:21:52 GMT 2025
PRIMARY
MERCK INDEX
m8286
Created by admin on Mon Mar 31 21:21:52 GMT 2025 , Edited by admin on Mon Mar 31 21:21:52 GMT 2025
PRIMARY Merck Index
NSC
53102
Created by admin on Mon Mar 31 21:21:52 GMT 2025 , Edited by admin on Mon Mar 31 21:21:52 GMT 2025
PRIMARY
WIKIPEDIA
Oxamic acid
Created by admin on Mon Mar 31 21:21:52 GMT 2025 , Edited by admin on Mon Mar 31 21:21:52 GMT 2025
PRIMARY
CHEBI
18058
Created by admin on Mon Mar 31 21:21:52 GMT 2025 , Edited by admin on Mon Mar 31 21:21:52 GMT 2025
PRIMARY
ECHA (EC/EINECS)
207-443-0
Created by admin on Mon Mar 31 21:21:52 GMT 2025 , Edited by admin on Mon Mar 31 21:21:52 GMT 2025
PRIMARY
NSC
49416
Created by admin on Mon Mar 31 21:21:52 GMT 2025 , Edited by admin on Mon Mar 31 21:21:52 GMT 2025
PRIMARY
MESH
D010072
Created by admin on Mon Mar 31 21:21:52 GMT 2025 , Edited by admin on Mon Mar 31 21:21:52 GMT 2025
PRIMARY